Ambrx Biopharma Inc - ADR

$6.10 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Ambrx Biopharma Inc - ADR

Ambrx Biopharma Inc. operates as a biotech company. The Company focuses on discovering and developing a novel class of engineered precision biologics (EPBs) using our proprietary expanded genetic code technology platform that allows us to incorporate, in a site-specific manner, synthetic amino acids (SAAs) into proteins within living cells.

Stock Analysis

last close $6.1
1-mo return -37.8%
3-mo return -46.7%
avg daily vol. 28.75T
52-week high 22.87
52-week low 5.18
market cap. $235M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $11M
inst own. 38.9%
baraka

Subscribe now for daily local and international financial news

Subscribe